Worldwide study on physical and mental health effects of Covid-19 is underway

A worldwide study looking at the effect of Covid-19 on physical and mental health is underway.

Over 50k people have taken part so far in the online survey, which will measure the impact of the virus over an 18-month period.

The survey looks at how people have been feeling in the last two weeks and how they felt within the two weeks before the pandemic.

Dr Trevor Thompson from the University of Greenwich is helping to analyze the UK data, which is being collected by ten scientists at seven universities including Greenwich, Oxford and King's College London.

He said: "The immediate aim is to see who has been affected most by the virus, in terms of wellbeing and to identify ways in which the UK population may have been uniquely affected.

"The long-term aim is to look at the most vulnerable to see how they can be helped in future pandemics. This is a chance for us all to contribute to something which affects the whole planet."

The Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) is taking place in over 100 countries that have been affected by Covid-19 and is set to become one of the biggest such studies ever.

It is endorsed by the World Psychiatric Association and aims to identify risk and protective factors for physical and mental health problems, and to guide strategies for remedying these problems.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients